🦴 Category

rheumatology

13 papers

Rheumatology focuses on understanding and treating conditions that cause pain, swelling, and stiffness in the joints, muscles, and connective tissues. From common issues like arthritis to complex autoimmune disorders, this vital field seeks to improve quality of life for millions of people living with chronic inflammation. Because medical research moves fast, staying updated with the latest discoveries can be challenging without a clear guide.

At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you never miss a breakthrough. We transform these raw studies into both plain-language overviews and detailed technical summaries, making complex findings accessible to everyone regardless of their background. Below are the latest papers in rheumatology that have been recently analyzed and summarized for you.

A Bibliometric and Content Analysis of Exercise Interventions Research in Rheumatoid Arthritis

This study combines bibliometric mapping and structured content analysis of research from 2016 to 2025 to reveal that while exercise interventions for rheumatoid arthritis are increasingly focused on patient-centered outcomes, the evidence base remains imbalanced with robust data for aerobic and resistance training but limited depth for emerging modalities like mind-body and high-intensity interval training.

Zou, Z., Zhang, Z., Zhao, R., Liu, Y., Gao, J., Gu, L.2026-05-28🦴 rheumatology

Course of Itch from Systemic Sclerosis Onset: a Scleroderma Patient-Centred Intervention Network Cohort Longitudinal Study

This longitudinal study of over 2,000 systemic sclerosis patients reveals that itch is a common and moderately severe symptom that remains stable in both prevalence and intensity regardless of disease onset age or duration, challenging the previous belief that itch is most significant only in early disease.

Goldberg, M., Carrier, M.-E., Yosipovitch, G., Dal Santo, C., Kwakkenbos, L., Frech, T., Hoa, S., Netchiporouk, E., Misery, L., Lapointe McKenzie, J.-A., Mieszczak, T., Rideout, S., Sauve, M., Philip (…)2026-04-02🦴 rheumatology

cliexa-RA Implementation in Colorado Arthritis Center: A Case Study of Quadruple Aim Impacts

A six-month pilot study at the Colorado Arthritis Center demonstrates that the cliexa-RA digital platform significantly enhances rheumatoid arthritis management by reducing patient intake and clinician documentation times by 52% and 77% respectively, while simultaneously improving patient satisfaction, workflow efficiency, and administrative cost-effectiveness within the Quadruple Aim framework.

Kazgan, M.2026-04-01🦴 rheumatology

Type-1 interferon-driven innate and GZMK+ CD8 T cell activation precedes subclinical joint inflammation when rheumatoid arthritis is imminent

This study identifies that type-1 interferon-driven activation of specific immune cells precedes subclinical joint inflammation in individuals at imminent risk of rheumatoid arthritis, while a shift toward tissue-directed inflammatory and cytotoxic programs occurs concurrently with the onset of detectable synovitis.

Tariq, F., Martin, P., Abacar, K., Ye, W., Sun, S., Mackay, S., Muldoon, D., Sharrack, S., Menon, M., Al-Mossawi, H., Buch, M. H., Emery, P., Newton, D., Fairfax, B., Mankia, K.2026-03-30🦴 rheumatology

The results of Transcriptome-wide Mendelian Randomization (TWMR) in large-scale populations can directly validate, across scales, the results of causal inference from deep learning combined with double machine learning on single-cell transcriptomes of human samples.

This study demonstrates that transcriptome-wide Mendelian randomization results from large-scale population data significantly correlate with causal inferences derived from deep learning and double machine learning on single-cell transcriptomes, thereby validating a cross-scale convergence of statistical and systems biology that bridges the translational gap in understanding complex diseases like rheumatoid arthritis.

ye, w., Jiang, X., Shen, F.2026-03-19🦴 rheumatology

Efficacy and Safety of Iguratimod Combined with Yunke Injection in the Treatment of Ankylosing Spondylitis

This retrospective cohort study demonstrates that combining Iguratimod with Yunke injection is a safe and effective alternative treatment for Ankylosing Spondylitis patients with contraindications to biologics or JAK inhibitors, offering superior disease activity improvement and reduced NSAID dependency compared to Iguratimod monotherapy without increasing adverse reactions.

shiyu, z., chen, l.2026-03-17🦴 rheumatology

A comprehensive descriptive analysis of hip and knee radiographic osteoarthritis in the UK Biobank in relation to joint pain, joint site interrelationships, obesity, race and deprivation: Findings from 59,475 individuals

This study of 59,475 UK Biobank participants reveals that radiographic hip and knee osteoarthritis exhibit distinct patterns of inter-joint relationships, symptom associations, and risk factor profiles, highlighting the heterogeneity of the disease and the need for joint-specific treatment approaches.

Hashmi, A., Scott, S., Jung, M., Saunders, F. R., Ebsim, R., Gregory, J. S., Arbeeva, L., Nelson, A. E., Harvey, N. C., Lindner, C., Aspden, R. M., Cootes, T., Tobias, J. H., Faber, B. G.2026-03-17🦴 rheumatology

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies

This study establishes autoantibody internalization as a shared pathogenic mechanism across diverse autoimmune diseases by demonstrating that patient-derived antibodies enter cells, induce specific transcriptomic signatures and inflammatory responses in multiple cell types, and drive tissue damage through a unified framework.

Pinal-Fernandez, I., Pak, K., Casal-Dominguez, M., Munoz-Braceras, S., Wigerblad, G., Dell'Orso, S., Naz, F., Islam, S., Gutierrez-Cruz, G., Kinder, T. B., Ogbonnaya-Whittlesey, S. A., Fernandez-Codin (…)2026-03-05🦴 rheumatology

A Common Missense Variant, W335S, in β2-Glycoprotein I (APOH) is Associated with Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk

This study identifies the W335S missense variant in the APOH gene as a causal factor that paradoxically increases anti-β2-glycoprotein I autoantibody levels while simultaneously reducing venous thromboembolism risk by disrupting phospholipid binding, thereby uncoupling autoimmunity from thrombosis and offering a potential biomarker for thrombotic risk stratification.

Lalaurie, C., Liu, L., Khan, A., Wang, C., Rich, S., Barr, R. G., Bernstein, E., Kiryluk, K., McDonnell, T. C. R., Luo, Y.2026-03-05🦴 rheumatology

Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis

This study reveals that mosaic chromosomal alterations, specifically autosomal copy-number loss (Loss) and mosaic loss of heterozygosity (mLOX), are significantly and differentially associated with systemic sclerosis and its clinical subtypes, particularly in patients with late-onset disease and high cell fractions, suggesting these genetic events contribute to the phenotypic heterogeneity of the condition.

Nishio, Y., Ishikawa, Y., Uchiyama, S., Liu, X., Takada, S., Kuroshima, T., Yoshifuji, h., Kodera, M., Akahoshi, M., Niiro, H., Motegi, S.-i., Hasegawa, M., Asano, Y., Nakayamada, S., Tanaka, Y., Koya (…)2026-03-03🦴 rheumatology